Furthermore, Reynold et al. have reported that the adoptive transfer of CD4+CD25+ Tregs can modulate immune responses in the brain, resulting in significant neuroprotection in a PD mouse model (Reynolds et al., 2007). This evidence concerns the gene CD4 and Parkinson disease.